9/24
10:34 am
fgen
FibroGen (NASDAQ:FGEN) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $43.00 price target on the stock.
Low
Report
FibroGen (NASDAQ:FGEN) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $43.00 price target on the stock.